Burkina Faso vs Guinea-Bissau: Meningococcal A conjugate (MENGA) vaccine immunization coverage (%)
Burkina Faso
66.0%
in 2025
Guinea-Bissau
65.0%
in 2025
Burkina Faso rank
7th
Guinea-Bissau rank
8th
Meningococcal A conjugate (MENGA) vaccine immunization coverage (%) over time
- Burkina Faso
- Guinea-Bissau
How they compare
Burkina Faso currently reports 66.0% against 65.0% in Guinea-Bissau, a difference of 1.0%.
The two have swapped places 1 time across 10 shared years of data; in 2016 it was Guinea-Bissau ahead.
Burkina Faso ranks 7th and Guinea-Bissau ranks 8th of 26 countries.
Burkina Faso has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Burkina Faso | Guinea-Bissau | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 52.2% | 0.0% | 52.2% | Burkina Faso |
| 2020s | 68.0% | 28.3% | 39.7% | Burkina Faso |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher meningococcal a conjugate (menga) vaccine immunization coverage (%), Burkina Faso or Guinea-Bissau?
- Burkina Faso, at 66.0% against 65.0% in Guinea-Bissau as of 2025.
- What is the difference in meningococcal a conjugate (menga) vaccine immunization coverage (%) between Burkina Faso and Guinea-Bissau?
- 1.0%, with Burkina Faso ahead.
- How many years of comparable data are there for Burkina Faso and Guinea-Bissau?
- 10 years are reported by both, from 2016 to 2025.
- How do Burkina Faso and Guinea-Bissau rank globally for meningococcal a conjugate (menga) vaccine immunization coverage (%)?
- Burkina Faso ranks 7th and Guinea-Bissau ranks 8th of 26 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Meningococcal A conjugate (MENGA) vaccine immunization coverage (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.